Reckitt Benckiser Group/£RKT

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a global consumer health, hygiene, and home products company. Founded in 1819 and headquartered in Slough, England, it operates in numerous sectors including health, hygiene, and home products. The company produces a broad spectrum of well-known brands such as Dettol, Lysol, and Durex, catering to consumers worldwide.

Ticker

£RKT

Primary listing

LSE

Industry

Household Products

Employees

37,900

ISIN

GB00B24CGK77

RKT Metrics

BasicAdvanced
£35B
25.15
£2.03
0.07
£2.02
3.95%

What the Analysts think about RKT

Analyst ratings (Buy, Hold, Sell) for Reckitt Benckiser Group stock.

Bulls say / Bears say

Reckitt's business in China is thriving, with double-digit annual sales growth, particularly in products like Dettol disinfectants. (reuters.com)
The company is divesting its underperforming homecare brands, including Air Wick and Cillit Bang, to focus on higher-margin health and hygiene products. (reuters.com)
Analysts have upgraded Reckitt's stock rating to 'strong-buy,' reflecting confidence in the company's strategic direction and growth prospects. (marketbeat.com)
Reckitt missed its fourth-quarter sales expectations, primarily due to reduced demand for over-the-counter medicines during a late flu and cold season. (reuters.com)
The company faces higher costs or may need to raise prices in the U.S. due to exposure to new tariffs on imports from Mexico and other regions, as only 57% of its U.S. sales volumes are locally manufactured. (reuters.com)
Reckitt's shares fell to an 11-year low after a verdict against Abbott Laboratories intensified concerns over infant formula lawsuits faced by both companies. (bloomberg.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

RKT Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

RKT Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £RKT

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs